News & Blog

Tag Archives: GBM

Glossary Blog, February 2018: CAR T-Cell Therapy

CAR T-cell Therapy: A type of treatment in which a patient’s T-cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T-cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is […]

NBTS Brain Tumor Clinical Trials Report: January/February 2018

New brain tumor clinical trials open around the world all the time, and it can be hard for patients and care-partners to keep track of new opportunities to potentially participate in leading-edge clinical research. This report, generated by the National Brain Tumor Society, provides you with a summary of clinical trials that have begun recruitment […]

2018 Crystal Ball: Predictions & Hopes for Advances in Brain Tumor Research and Treatments in the New Year

Last year, progress continued to build in the fight against brain tumors. Two products were given FDA approval for use in the treatment of brain tumors, the first such approvals since the Optune device was approved for use in newly diagnosed glioblastoma patients in 2015. There is still much work to be done, but advances […]

Share